Assura’s (AGR) “Hold” Rating Reiterated at Shore Capital

Shore Capital reissued their hold rating on shares of Assura (LON:AGR) in a research note published on Wednesday, MarketBeat.com reports.

Separately, Peel Hunt restated a “buy” rating and issued a GBX 60 price objective on shares of Assura in a report on Tuesday. One equities research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of GBX 60.

Assura Price Performance

Shares of LON AGR opened at GBX 47.48 on Wednesday. The stock has a market capitalization of £1.54 billion, a price-to-earnings ratio of 895.85, a PEG ratio of 3.60 and a beta of 0.37. The business has a 50-day moving average of GBX 47.94 and a 200-day moving average of GBX 48.48. The company has a debt-to-equity ratio of 85.05, a current ratio of 0.89 and a quick ratio of 2.84. Assura has a fifty-two week low of GBX 35.24 and a fifty-two week high of GBX 50.95.

Assura (LON:AGR) last announced its quarterly earnings data on Monday, July 21st. The real estate investment trust reported GBX 3.50 earnings per share for the quarter. Assura had a negative return on equity of 1.92% and a negative net margin of 18.09%. As a group, sell-side analysts predict that Assura will post 3.5830389 earnings per share for the current fiscal year.

Insider Activity

In related news, insider Sam Barrell sold 34,153 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of GBX 48, for a total value of £16,393.44. Also, insider Jonathan Murphy sold 1,394,556 shares of the firm’s stock in a transaction dated Tuesday, August 12th. The shares were sold at an average price of GBX 50, for a total transaction of £697,278. Over the last quarter, insiders have acquired 2,540 shares of company stock valued at $125,674 and have sold 5,182,149 shares valued at $258,872,495. Insiders own 0.93% of the company’s stock.

About Assura

Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.

We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.